Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
566-04-011 MRI in Clinical Practice Abstract

MRI in Clinical Practice: Non-contrast Rapid STAGE Imaging for Evaluation of Brain Abnormalities in Sturge-Weber Syndrome

Accepted
Scotty McKay1, Yongsheng Chen 2,3, E. Mark Haacke1,2,3, Yang Xuan1, Aimee Luat4, Csaba Juhasz3,5
1Radiology, Detroit Medical Center/Wayne State, Detroit, United States of America
2Biomedical Engineering, Wayne State School of Medicine, Detroit, United States of America
3Neurology, Wayne State School of Medicine, Detroit, United States of America
4Pediatrics, Children's Hospital of Michigan, Detroit, United States of America
5Pediatrics, Wayne State School of Medicine, Detroit, United States of America
Presenting Author: Yongsheng Chen

Synopsis

Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. Thomas-Sohl, K. A., Vaslow, D. F., & Maria, B. L. (2004). Sturge-Weber Syndrome: A Review. Pediatric Neurology, 30(5), 303–310. https://doi.org/10.1016/j.pediatrneurol.2003.12.015 [doi]
2. Juhasz C, Haacke M, Hu J, et al. Multimodality imaging of cortical and white matter abnormalities in Sturge-Weber syndrome. AJNR Am J Neuroradiol. 2007;28:900-906. PMID: 17494666 [pmid]
3. Juhász, C., Luat, A. F., Behen, M. E., Gjolaj, N., Jeong, J.-W., Chugani, H. T., & Kumar, A. (2023). Deep venous remodeling in unilateral Sturge-Weber Syndrome: Robust hemispheric differences and clinical correlates. Pediatric Neurology, 139, 49–58. https://doi.org/10.1016/j.pediatrneurol.2022.11.011 [doi]
4. Sabeti, S., Ball, K. L., Bhattacharya, S. K., Bitrian, E., Blieden, L. S., Brandt, J. D., Burkhart, C., Chugani, H. T., Falchek, S. J., Jain, B. G., Juhasz, C., Loeb, J. A., Luat, A., Pinto, A., Segal, E., Salvin, J., & Kelly, K. M. (2021). Consensus statement for the management and treatment of Sturge-Weber Syndrome: Neurology, neuroimaging, and ophthalmology recommendations. Pediatric Neurology, 121, 59–66. https://doi.org/10.1016/j.pediatrneurol.2021.04.013 [doi]
5. Kannikeswaran N, Mahajan PV, Sethuraman U, Groebe A, Chen X. Sedation medication received and adverse events related to sedation for brain MRI in children with and without developmental disabilities. Paediatr Anaesth. 2009;19(3):250-256. doi: 10.1111/j.1460-9592.2008.02900.x [doi]
6. Stanescu AL, Shaw DW, Murata N, et al. Brain tissue gadolinium retention in pediatric patients after contrast-enhanced magnetic resonance exams: pathological confirmation. Pediatr Radiol. 2020;50(3):388-396. doi: 10.1007/s00247-019-04535-w [doi]
7. Towbin AJ, Zhang B, Dillman JR. Evaluation of the effect of multiple administrations of gadopentetate dimeglumine or gadoterate meglumine on brain T1-weighted hyperintensity in pediatric patients. Pediatr Radiol. 2021;51(13):2568-2580. doi: 10.1007/s00247-021-05134-4 [doi]
8. Gräfe D, Simion SH, Rosolowski M, et al. Brain deposition of gadobutrol in children—a cross-sectional and longitudinal MRI T1 mapping study. Eur Radiol. 2023;33(7):4580-4588. doi: 10.1007/s00330-022-09297-y [doi]
9. Jackson DB, MacIntyre T, Duarte-Miramontes V, DeAguero J, Escobar GP, Wagner B. Gadolinium deposition disease: a case report and the prevalence of enhanced MRI procedures within the Veterans Health Administration. Fed Pract. 2022;39(5):218-225. doi: 10.12788/fp.0258 [doi]
10. Juhász, C., Behen, M. E., Gjolaj, N., Luat, A. F., Xuan, Y., & Jeong, J.-W. (2024). Feasibility and potential diagnostic value of noncontrast brain MRI in nonsedated children with Sturge-Weber Syndrome and healthy siblings. Journal of Child Neurology, 39(9–10), 343–353. https://doi.org/10.1177/08830738241272064 [doi]
11. Chen Y, Liu S, Wang Y, Kang Y, Haacke EM. STrategically Acquired Gradient Echo (STAGE) imaging, part I: Creating enhanced T1 contrast and standardized susceptibility weighted imaging and quantitative susceptibility mapping. Magn Reson Imaging. 2018 Feb;46:130-139. doi: 10.1016/j.mri.2017.10.005. [doi]
12. Wang, Y., Chen, Y., Wu, D., Wang, Y., Sethi, S. K., Yang, G., Xie, H., Xia, S., & Haacke, E. M. (2018). STrategically acquired Gradient Echo (stage) imaging, part II: Correcting for RF inhomogeneities in estimating T1 and Proton density. Magnetic Resonance Imaging, 46, 140–150. https://doi.org/10.1016/j.mri.2017.10.006 [doi]
13. Haacke, E. M., Chen, Y., Utriainen, D., Wu, B., Wang, Y., Xia, S., He, N., Zhang, C., Wang, X., Lagana, M. M., Luo, Y., Fatemi, A., Liu, S., Gharabaghi, S., Wu, D., Sethi, S. K., Huang, F., Sun, T., Qu, F., … Yan, F. (2020). STrategically acquired Gradient Echo (stage) imaging, part III: Technical advances and clinical applications of a rapid multi-contrast multi-parametric brain imaging method. Magnetic Resonance Imaging, 65, 15–26. doi: 10.1016/j.mri.2019.09.006 [doi]

Cite this abstract